RPG Life Sciences’ Quarterly Dose: Top-Line Growth, Bottom-Line Pain

RPG Life Sciences reported consolidated revenue of 1.8 billion rupees in Q3 FY26, up marginally year-on-year. However, net profit fell sharply to 221.3 million rupees, reflecting margin pressures. The results highlight stable top-line growth but significant profitability challenges amid rising costs and competitive pressures.

Show more

Stay Ahead – Explore Now! Dodla Dairy Posts Robust Q3 Earnings with Strong Revenue Growth